FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

M Hirata

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Concepts & Ideas

Physiology

Procedures

Co-author Network

Publications

TOP 3
M Hirata; Katsuyuki Kusuzaki; Yasusuke Hirasawa
Eleven cases of intraosseous lipoma of the calcaneus.
S Nakamura; Katsuyuki Kusuzaki; Hiroaki Murata; Hideyuki Takeshita; M Hirata; Shin Hashiguchi; Yasusuke Hirasawa
Ceramic endoprosthesis for aggressive giant cell tumors near the knee: eight cases followed for more than 10 years.
M Hirata; Katsuyuki Kusuzaki; Hideyuki Takeshita; Shin Hashiguchi; Yasusuke Hirasawa; Tsukasa Ashihara
Drug resistance modification using pulsing electromagnetic field stimulation for multidrug resistant mouse osteosarcoma cell line.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of M Hirata (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: M Hirata; Katsuyuki Kusuzaki; Yasusuke Hirasawa
Eleven cases of intraosseous lipoma of the calcaneus.
Anticancer research 2001;21(6A):4099-103.
2001: S Nakamura; Katsuyuki Kusuzaki; Hiroaki Murata; Hideyuki Takeshita; M Hirata; Shin Hashiguchi; Yasusuke Hirasawa
Ceramic endoprosthesis for aggressive giant cell tumors near the knee: eight cases followed for more than 10 years.
International orthopaedics 2001;25(2):104-6.
2001: M Hirata; Katsuyuki Kusuzaki; Hideyuki Takeshita; Shin Hashiguchi; Yasusuke Hirasawa; Tsukasa Ashihara
Drug resistance modification using pulsing electromagnetic field stimulation for multidrug resistant mouse osteosarcoma cell line.
Anticancer research 2001;21(1A):317-20.
2000: Hiroaki Murata; Katsuyuki Kusuzaki; Hideyuki Takeshita; M Hirata; Shin Hashiguchi; K Emoto; Tsukasa Ashihara; Yasusuke Hirasawa
Assessment of chemosensitivity in patients with malignant bone and soft tissue tumors using thallium-201 scintigraphy and doxorubicin binding assay.
Anticancer research 2000;20(5C):3967-70.
2000: Hiroaki Murata; Katsuyuki Kusuzaki; M Hirata; Shin Hashiguchi; Yasusuke Hirasawa
Extraabdominal desmoid tumor with dissemination detected by thallium-201 scintigraphy.
Anticancer research 2000;20(5C):3963-6.
2000: Hideyuki Takeshita; Katsuyuki Kusuzaki; Hiroaki Murata; T Suginoshita; M Hirata; Shin Hashiguchi; Tsukasa Ashihara; M C Gebhardt; H J Mankin; Yasusuke Hirasawa
Osteoblastic differentiation and P-glycoprotein multidrug resistance in a murine osteosarcoma model.
British journal of cancer 2000;82(7):1327-31.
2000: S Nakamura; Katsuyuki Kusuzaki; Hiroaki Murata; Hideyuki Takeshita; M Hirata; Shin Hashiguchi; Yasusuke Hirasawa
More than 10 years of follow-up of two patients after total femur replacement for malignant bone tumor.
International orthopaedics 2000;24(3):176-8.
2000: T Suginoshita; Katsuyuki Kusuzaki; T Nagaoka; Hiroaki Murata; M Hirata; Shin Hashiguchi; Yasusuke Hirasawa
Case report: natural development of osteosarcoma from precancerous lesion.
Anticancer research 2000;20(1B):511-4.
1999: Katsuyuki Kusuzaki; M Hirata; Shin Hashiguchi; Hideyuki Takeshita; Hiroaki Murata; Tsukasa Ashihara; Yasusuke Hirasawa
Acquisition of multidrug resistance in osteosarcomas, analyzed by doxorubicin binding assay, and histologic response to chemotherapy.
Anticancer research 1999;19(6B):5159-62.
1999: Katsuyuki Kusuzaki; Hiroaki Murata; Hideyuki Takeshita; M Hirata; Shin Hashiguchi; Y Tsuji; S Nakamura; Tsukasa Ashihara; Yasusuke Hirasawa
Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1999;12(9):863-72.
1999: Katsuyuki Kusuzaki; Hideyuki Takeshita; Hiroaki Murata; M Hirata; Shin Hashiguchi; Tsukasa Ashihara; Yasusuke Hirasawa
Prognostic value of DNA ploidy response to chemotherapy in human osteosarcomas.
Cancer letters 1999;141(1-2):131-8.
1999: Katsuyuki Kusuzaki; M Hirata; Hideyuki Takeshita; Hiroaki Murata; Shin Hashiguchi; Tsukasa Ashihara; Yasusuke Hirasawa
Relationship between P-glycoprotein positivity, doxorubicin binding ability and histologic response to chemotherapy in osteosarcomas.
Cancer letters 1999;138(1-2):203-8.
1999: Katsuyuki Kusuzaki; Shin Hashiguchi; M Hirata; Hideyuki Takeshita; Hiroaki Murata; Tsukasa Ashihara; Yasusuke Hirasawa
Response of DNA ploidy to chemotherapy in primary and metastatic lesions in human osteosarcomas.
Cancer letters 1999;138(1-2):159-65.
1999: Katsuyuki Kusuzaki; Hideyuki Takeshita; Hiroaki Murata; M Hirata; Shin Hashiguchi; Tsukasa Ashihara; Yasusuke Hirasawa
Prognostic significance of DNA ploidy pattern in osteosarcomas in association with chemotherapy.
Cancer letters 1999;137(1):27-33.
1999: Hiroaki Murata; Katsuyuki Kusuzaki; Hideyuki Takeshita; M Hirata; Shin Hashiguchi; Tsukasa Ashihara; Yasusuke Hirasawa
Cytofluorometric DNA ploidy analysis in giant cell tumor of bone: histologic and prognostic value.
Cancer letters 1999;136(2):223-9.
1998: Katsuyuki Kusuzaki; Hideyuki Takeshita; Hiroaki Murata; M Hirata; Shin Hashiguchi; Tsukasa Ashihara; Yasusuke Hirasawa
Relation between cellular doxorubicin binding ability to nuclear DNA and histologic response to preoperative chemotherapy in patients with osteosarcoma.
Cancer 1998;82(12):2343-9.
1998: Hideyuki Takeshita; Katsuyuki Kusuzaki; Y Tsuji; M Hirata; Shin Hashiguchi; S Nakamura; Hiroaki Murata; Tsukasa Ashihara; Yasusuke Hirasawa
Avoidance of doxorubicin resistance in osteosarcoma cells using a new quinoline derivative, MS-209.
Anticancer research 1998;18(2A):739-42.